Evidence map›Paper›PMID 31455870›Full record

ArticleInternational journal of obesity (2005)2019

Specific diacylglycerols generated by hepatic lipogenesis stimulate the oncogenic androgen receptor activity in male hepatocytes.

Ya-Wen Cheng, Kai-Wei Chen, Han-Chun Kuo, Ching-Hua Kuo, Wei-Hsiang Lin, Pei-Jer Chen, Shiou-Hwei Yeh

Open access · hybridAbstract read
PubMed Publisher
In one paragraph

Article in International journal of obesity (2005), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Constitutively Active Androgen Receptor in Hepatocellular Carcinoma.International journal of molecular sciences · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Ya-Wen ChengDepartment of Microbiology, National Taiwan University College of Medicine, Taipei, 100, Taiwan.
Kai-Wei ChenDepartment of Microbiology, National Taiwan University College of Medicine, Taipei, 100, Taiwan.
Han-Chun KuoThe Metabolomics Core Laboratory, Center of Genomic Medicine, National Taiwan University, Taipei, 100, Taiwan.
Ching-Hua KuoThe Metabolomics Core Laboratory, Center of Genomic Medicine, National Taiwan University, Taipei, 100, Taiwan.
Wei-Hsiang LinNTU Centers of Genomic and Precision Medicine, National Taiwan University, Taipei, 100, Taiwan.
Pei-Jer ChenDepartment of Microbiology, National Taiwan University College of Medicine, Taipei, 100, Taiwan.
Shiou-Hwei YehDepartment of Microbiology, National Taiwan University College of Medicine, Taipei, 100, Taiwan. shyeh@ntu.edu.tw.ORCID http://orcid.org/0000-0003-4509-180X
National Taiwan University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundObesity-induced hepatocellular carcinoma (HCC) is more prevalent in males than in females, but the underlying mechanism remains unclear. The influence of hepatic androgen receptor (AR) pathway on the gender difference of HCC has been well documented. Here we investigated the role of hepatic lipogenesis, which is elevated in the livers of obese and nonalcoholic fatty liver disease (NAFLD) patients, in stimulating the AR pathway for the male preference of obesity induced HCC.

methodsMale C57BL/6J mice were fed a fructose-rich high carbohydrate diet (HCD) to induce hepatic lipogenesis. The effect of hepatic lipogenesis on AR was examined by the expression of hydrodynamically injected AR reporter and the endogenous AR target gene; the mechanism was delineated in hepatoma cell lines and validated in male mice.

resultsThe hepatic lipogenesis induced by a fructose-rich HCD enhanced the transcriptional activity of hepatic AR in male mice, which did not happen when fed a high fat diet. This AR activation was blocked by sh-RNAs or inhibitors targeting key enzymes in lipogenesis, either acetyl-CoA carboxylase subunit alpha (ACCα), or fatty acid synthase (FASN), in vivo and in vitro. Further mechanistic study identified that specific unsaturated fatty acid, the oleic acid (C18:1 n-9), incorporated DAGs produced by hepatic lipogenesis are the key molecules to enhance the AR activity, through activation of Akt kinase, and this novel mechanism is targeted by metformin.

conclusionsOur study elucidates a novel mechanism underlying the higher risk of HCC in obese/NAFLD males, through specific DAGs enriched by hepatic lipogenesis to increase the transcriptional activity of hepatic AR, a confirmed risk factor for male HCC.

Indexed as

DiglyceridesReceptors, AndrogenAnimalsCells, CulturedFemaleHepatocytesLipogenesisLiverMaleMiceMice, Inbred C57BLDiglyceridesReceptors, Androgen

Identifiers

PMID31455870
OpenAlexW2971169394

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.